SEC Form 4 · accession 0000899243-18-012080
Apellis Pharmaceuticals, Inc. · APLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Federico Grossi
Officer — See Remarks
Period of report
May 7, 2018
Accepted (ET)
May 9, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492422
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 7, 2018 | J | 7,706 | $0.00 | A | 16,206 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution from Potentia Holdings, LLC, of which the reporting person is a non-managing member.
Remarks
Executive Vice President - Clinical Development